RARE
NASDAQ · Biotechnology
Ultragenyx Pharmaceutical In
$25.02
+0.11 (+0.44%)
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Q3 FY2026 | $-1.25 | — | — | — | — |
| May 4, 2026 | Q2 FY2026 | $-1.50 | — | — | — | — |
| Feb 12, 2026 | Q1 FY2026 | $-1.13 | — | — | — | — |